B. Twelve, Inc.
Records under this name other than patents B. Twelve, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to B. Twelve, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,688,504 | Anti-receptor and growth blocking antibodies to the vitamin B.sub.12 /transcobalamin II receptor and binding sites Term ended Term ended no later than Nov 18, 2017 · Low confidence | Term ended | Term ended no later than Nov 18, 2017 | Low confidence |
| US 5,739,287 | Biotinylated cobalamins Term ended Term ended no later than Apr 14, 2018 · Low confidence | Term ended | Term ended no later than Apr 14, 2018 | Low confidence |
| US 5,840,712 | Water soluble vitamin B.sub.12 receptor modulating agents and methods related thereto Term ended Term ended no later than Nov 24, 2018 · Low confidence | Term ended | Term ended no later than Nov 24, 2018 | Low confidence |
| US 5,840,880 | Receptor modulating agents Term ended Term ended no later than Nov 24, 2018 · Low confidence | Term ended | Term ended no later than Nov 24, 2018 | Low confidence |
| US 5,869,465 | Methods of receptor modulation and uses therefor Term ended Term ended no later than Feb 9, 2019 · Low confidence | Term ended | Term ended no later than Feb 9, 2019 | Low confidence |